36B6:F:F-iShares MSCI USA SRI UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 10.492

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.09 (-0.31%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.21 (-0.41%)

USD 114.13B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.28 (+0.05%)

USD 106.46B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 100.12B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.06 (-0.40%)

USD 63.18B
VUSA:F Vanguard Funds Public Limited ..

-0.61 (-0.56%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.98 (-0.90%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.80 (-0.33%)

USD 51.11B
XJSE:F Xtrackers II - Japan Governmen..

+0.06 (+0.77%)

USD 43.12B
0ZC:F Zscaler Inc

+2.50 (+1.39%)

USD 37.92B

ETFs Containing 36B6:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.98% 61% D- 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.98% 60% D- 54% F
Trailing 12 Months  
Capital Gain 20.11% 76% C+ 70% C-
Dividend Return 1.39% 10% F 11% F
Total Return 21.50% 75% C 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.83% 55% F 56% F
Dividend Return 5.89% 53% F 49% F
Total Return 0.06% 6% D- 2% F
Risk Return Profile  
Volatility (Standard Deviation) 9.70% 69% C- 91% A-
Risk Adjusted Return 60.79% 64% D 73% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.